Concepedia

Kanupriya Whig

KW

11

Publications

899

Citations

11

H-Index

2017

Active since

Affiliations

University of Pennsylvania(Current)

National Center for Advancing Translational Sciences

Medicines for Malaria Venture

National Institutes of Health

Thomas Jefferson University

Kanupriya Whig is an author at University of Pennsylvania specializing in medicine, immunology, and drug discovery.

Top concepts

MedicineCovid-19VirologyImmunologyPharmacologyDrug DiscoveryPharmacotherapyGeneticsInflammationPathogenesis

Publications per year

2017–2022

11

Publications

11

Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2

Mark Dittmar, Jae Seung Lee, Kanupriya Whig et al. · Cell Reports · 2021 · 245 citations · Full text

Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2

D. Schultz, Robert M. Johnson, Kasirajan Ayyanathan et al. · Nature · 2022 · 192 citations · Full text

Pyrimidine Inhibitors, Medicine, Antiviral Drug Development +4

Pharmacological activation of STING blocks SARS-CoV-2 infection

Minghua Li, Max Ferretti, Baoling Ying et al. · Science Immunology · 2021 · 186 citations · Full text

Innate Immune Pathways, Innate Immune System, Immunology +16

Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer

Yong Gu Lee, Puneeth Guruprasad, Guido Ghilardi et al. · Cancer Discovery · 2022 · 86 citations · Full text

Drug repurposing screens reveal FDA approved drugs active against SARS-Cov-2

Mark Dittmar, Jae Seung Lee, Kanupriya Whig et al. · 2020 · 47 citations · Full text

Lung Cells, Drug Repositioning, Screens Reveal Fda +13

Rows per page

1–5 of 11